Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3045% below fair value
$83.82+0.86 (+1.04%)
Close on Nov 13, 2026Market cap $34.64BP/E 14.1Yield 2.42%
Zoetis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Zoetis's enterprise value was $41.57B on Nov 11, 2026, against $61.39B a year earlier. Over the last 5 years it ranged from $36.29B to $118.84B, with a median of $80.01B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $41.57B | -31.1% |
| 2025 | Dec 31, 2025 | $60.34B | -23.1% |
| 2024 | Dec 31, 2024 | $78.43B | -17.9% |
| 2023 | Dec 29, 2023 | $95.49B | +31.9% |
| 2022 | Dec 30, 2022 | $72.41B | -39.1% |
| 2021 | Dec 31, 2021 | $118.84B | +43.7% |
| 2020 | Dec 31, 2020 | $82.70B | +22.1% |
| 2019 | Dec 31, 2019 | $67.72B | +46.6% |
| 2018 | Dec 31, 2018 | $46.19B | +18.8% |
| 2017 | Dec 29, 2017 | $38.89B | +28.4% |
| 2016 | Dec 30, 2016 | $30.29B | +14.1% |
| 2015 | Dec 31, 2015 | $26.55B | +7.7% |
| 2014 | Dec 31, 2014 | $24.65B | +25.5% |
| 2013 | Dec 31, 2013 | $19.63B | – |
See a number that looks wrong?